Affigen raises $17M in series A

Cancer company Affigen Inc. (St. Louis, Mo.) raised $17 million in a series A round led by Black Beret Life Sciences.

The company is developing cancer immunotherapies targeting cell lineage-specific tumor proteins with an initial focus on hematological malignancies...